Indoleamine 2,3-dioxygenase 1 (IDO1) activity in leukemia blasts correlates with poor outcome in childhood acute myeloid leukemia.
about
Understanding the role of the kynurenine pathway in human breast cancer immunobiologyIDO in the Tumor Microenvironment: Inflammation, Counter-Regulation, and ToleranceTIM-3/Gal-9 interaction induces IFNγ-dependent IDO1 expression in acute myeloid leukemia blast cells.Increased expression of IDO associates with poor postoperative clinical outcome of patients with gastric adenocarcinoma.Novel Therapies for Acute Myeloid Leukemia: Are We Finally Breaking the Deadlock?Modulation of cancer-specific immune responses by amino acid degrading enzymes.The status of immunosuppression in patients with stage IIIB or IV non-small-cell lung cancer correlates with the clinical characteristics and response to chemotherapy.IDO1 involvement in mTOR pathway: a molecular mechanism of resistance to mTOR targeting in medulloblastoma.A novel immunohistochemical score to predict early mortality in acute myeloid leukemia patients based on indoleamine 2,3 dioxygenase expression.Discovery and application of immune biomarkers for hematological malignancies.Modulating Tumor Immunology by Inhibiting Indoleamine 2,3-Dioxygenase (IDO): Recent Developments and First Clinical Experiences.Integration of nano drug-delivery system with cancer immunotherapy.Targeting Leukemia Stem Cells in the Bone Marrow Niche.Targeting the Immune Microenvironment in Acute Myeloid Leukemia: A Focus on T Cell Immunity.
P2860
Q26773472-9641F515-7F0B-4C19-9D84-992CFA639E45Q34512092-FCEFBF0C-6200-4A6F-BD0D-B98A009FA79BQ35505155-CAD0871E-C68F-4C2D-8C70-DCEE97F5CA9EQ36591970-6A6A13FC-EC05-47B8-8A2A-E24FAD469EF7Q38664735-43F7FE51-A288-4F37-B06A-7EE5618F719EQ39045520-72FDDACD-23A3-4D80-8905-5EDC7F0FA960Q41149149-7B0A65A2-0F7C-49A6-AB66-A4DA5C4CF36BQ42324668-ED3EAFCC-095B-4192-8AAD-8D19FF19E3DAQ42379001-73CCF902-1570-44DA-B186-8BDDEF97D75EQ47681393-73EE44C8-8B6A-4AC6-B335-943D20B2FC27Q48306002-F50F21E3-4E04-4E97-B460-F5F9E8F68327Q48622958-5C2E4707-F1F9-4041-9CE5-8EA321B9E84CQ52375473-A2827C34-0B62-4A6D-9B75-9BD9BBAA5FC5Q55299267-DE0C4C3B-33D5-4261-80E8-AF84E07A1617
P2860
Indoleamine 2,3-dioxygenase 1 (IDO1) activity in leukemia blasts correlates with poor outcome in childhood acute myeloid leukemia.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Indoleamine 2,3-dioxygenase 1 ...... ldhood acute myeloid leukemia.
@ast
Indoleamine 2,3-dioxygenase 1 ...... ldhood acute myeloid leukemia.
@en
type
label
Indoleamine 2,3-dioxygenase 1 ...... ldhood acute myeloid leukemia.
@ast
Indoleamine 2,3-dioxygenase 1 ...... ldhood acute myeloid leukemia.
@en
prefLabel
Indoleamine 2,3-dioxygenase 1 ...... ldhood acute myeloid leukemia.
@ast
Indoleamine 2,3-dioxygenase 1 ...... ldhood acute myeloid leukemia.
@en
P2093
P2860
P50
P356
P1433
P1476
Indoleamine 2,3-dioxygenase 1 ...... ildhood acute myeloid leukemia
@en
P2093
Anna M Testi
Bianca M Goffredo
Franco Locatelli
Giovanni F Torelli
Giuseppina Bonanno
Perla Filippini
Riccardo Masetti
Roberta Caruso
Stefania Gaspari
Valentina Bertaina
P2860
P304
P356
10.18632/ONCOTARGET.1504
P407
P577
2014-04-01T00:00:00Z